Despite poor Q1 results, Elon Musk reaffirmed timelines for key projects. See why Tesla (TSLA) stock upgraded to a buy amid ...

Regeneron Pharmaceuticals stock was among the biggest S&P 500 and Nasdaq decliners Tuesday after the biotech firm reported ...

On April 24 this reporter posted an article titled “How much was Elon Musk’s pledge to step back from DOGE worth? $67 billion ...

Despite missing Q1 2025 expectations and delaying its FY 2025 guidance update, Tesla's stock is up by 20% since the results ...

Tesla, Inc.’s (TSLA) stock rose for a fifth straight session on Monday and has jumped about 23% since reporting a major ...

Elon Musk's vocal and financial backing of Donald Trump's presidential campaign led many observers to predict significant ...

BI examined sentiment data, markets chaos, and interviews with small business owners, consumers, and economists. They point ...